May 14, 2020 / 2:55 PM / 24 days ago

BRIEF-Bioporto: Danish Team Of Researchers To Test Treatment Of Critically Ill Patients Suffering From COVID-19

May 14 (Reuters) - Bioporto A/S:

* DANISH TEAM OF RESEARCHERS TO TEST TREATMENT OF CRITICALLY ILL PATIENTS SUFFERING FROM COVID-19

* INNOVATION FUND DENMARK HAS AWARDED DKK 3 MILLION TO TEST IF DRUG ILOPROST CAN IMPROVE SURVIVAL RATES IN SARS-CO-V2 INFECTED PATIENTS IN NEED OF RESPIRATORY TREATMENT

* STUDY WILL BE CONDUCTED IN A PARTNERSHIP BETWEEN LEADING HOSPITALS IN CAPITAL REGION OF DENMARK AND BIOPORTO A/S, A DANISH DIAGNOSTICS COMPANY

* INTENTION OF STUDY IS TO COMPARE EFFICACY OF ILOPROST TO PLACEBO IN A GROUP OF 80 PATIENTS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below